Archives

• 2022-01-24
  NEWS
  Dr. Vaijayanthi THANGAVEL takes in charge as Chief Executing Officer
• 2019-09-05
  NEWS
  Concluded license agreement for the patent of RUNX inhibitor with Kyoto University.
• 2019-02-18
  NEWS
  Our web site has been created.